Caricamento...
The Safety of Peanut Oral Immunotherapy in Peanut Allergic Subjects in a Single-Center Trial
BACKGROUND: Peanut allergy is the leading cause of food-related anaphylaxis and accidental exposures are common. Oral immunotherapy has been posited as a potential treatment. METHODS: Patients ages 3–65 with peanut-specific IgE ≥ 7 kU/L and/or a positive skin prick test with a history of an allergic...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3505766/ https://ncbi.nlm.nih.gov/pubmed/22678151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000336391 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|